Lung Cancer
Share this page:
The CyberKnife® Radiosurgery Solution: Early stage Bronchogenic Carcinoma
Overview
Stereotactic radiosurgery, sometimes also referred to in the literature as stereotactic radiotherapy, is a new technique that shows great promise in the treatment of early stage bronchogenic carcinomas in medically unresectable patients, with published local control rates approaching 100% in the higher dose arms, albeit with relatively short follow-up (10, 11,12, 13).
CyberKnife® Technical Solutions:
CyberKnife® radiosurgery effectively addresses all of the technical limitations of standard radiotherapy described above, resulting in a very sophisticated method to deliver a far more biologically potent dose of radiation to an early stage bronchogenic carcinoma lesion, with surgical precision. Briefly, these include:
Written by Donald B. Fuller, M.D. – Radiation Oncologist